![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 51, 50183-50189, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Little is known regarding factors that induce
parasympathetic responsiveness during cardiac development. We
demonstrated previously that in atrial cells cultured from chicks 14 days in ovo, transforming growth factor
Transforming Growth Factor
(TGF
) Signaling via
Differential Activation of Activin Receptor-like Kinases 2 and 5 during Cardiac Development
ROLE IN REGULATING PARASYMPATHETIC RESPONSIVENESS*
,
**
Cardiovascular Division, Department of
Medicine, Brigham and Women's Hospital and Harvard Medical School,
Boston, Massachusetts 02115 and § Department of
Pharmacology, Vanderbilt University Medical Center,
Nashville, Tennessee 37232-6400
(TGF
)
decreased parasympathetic inhibition of beat rate by the muscarinic
agonist, carbamylcholine, by 5-fold and decreased expression of
G
i2. Here in atrial cells 5 days in ovo,
TGF
increased carbamylcholine inhibition of beat rate 2.5-fold and
increased expression of G
i2. TGF
also stimulated G
i2 mRNA expression and promoter activity at day 5 while inhibiting them at day 14 in ovo. Over the same time
course expression of type I TGF
receptors, chick activin
receptor-like kinase 2 and 5 increased with a 2.3-fold higher increase
in activin receptor-like kinase 2. Constitutively active activin
receptor-like kinase 2 inhibited G
i2 promoter activity,
whereas constitutively active activin receptor-like kinase 5 stimulated
G
i2 promoter activity independent of embryonic age. In
5-day atrial cells, TGF
stimulated the p3TP-lux reporter, which is
downstream of activin receptor-like kinase 5 and had no effect on the
activity of the pVent reporter, which is downstream of activin
receptor-like kinase 2. In 14-day cells, TGF
stimulated both pVent
and p3TP-lux. Thus TGF
exerts opposing effects on parasympathetic
response and G
i2 expression by activating different type
I TGF
receptors at distinct stages during cardiac development.
*
This work was supported by National Institutes of Health
Grants HL54225 (to J. B. G.) and HL52922 (to J. V. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
H.-J. Park, S. M. Ward, J. S. Desgrosellier, S. P. Georgescu, A. G. Papageorge, X. Zhuang, J. V. Barnett, and J. B. Galper Transforming Growth Factor beta Regulates the Expression of the M2 Muscarinic Receptor in Atrial Myocytes via an Effect on RhoA and p190RhoGAP J. Biol. Chem., July 21, 2006; 281(29): 19995 - 20002. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |